This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Malvankar-Mehta MS, et al. North American cost analysis of brand name versus generic drugs for the treatment of glaucoma. ClinicoEconomics and Outcomes Research 2019: 789-798, No. 11, 16 Dec 2019. Available from: URL: https://doi.org/10.2147/CEOR.S156558
About this article
Cite this article
Brand-name drugs for glaucoma more costly than generics. PharmacoEcon Outcomes News 844, 9 (2020) doi:10.1007/s40274-020-6472-7